Avidity Partners Management LP
- SEC CIK
- 0001791827
- Latest filing
- Aug 14, 2026
AXSM holding history
Axsome Therapeutics, Inc. in every 13F filed by Avidity Partners Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −94,500−100.0% | Sold out | Holders |
| Q2 2025 | 94,500 | $9.86M | 2.0% | +17,500+22.7% | Added | Holders |
| Q1 2025 | 77,000 | $8.98M | 1.9% | −111,000−59.0% | Reduced | Holders |
| Q4 2024 | 188,000 | $15.9M | 1.6% | −108,100−36.5% | Reduced | Holders |
| Q3 2024 | 296,100 | $26.6M | 1.4% | −79,900−21.3% | Reduced | Holders |
| Q2 2024 | 376,000 | $30.3M | 1.3% | −55,000−12.8% | Reduced | Holders |
| Q1 2024 | 431,000 | $34.4M | 1.2% | −28,400−6.2% | Reduced | Holders |
| Q4 2023 | 459,400 | $36.6M | 1.4% | +162,600+54.8% | Added | Holders |
| Q3 2023 | 296,800 | $20.7M | 0.8% | −248,200−45.5% | Reduced | Holders |
| Q2 2023 | 545,000 | $39.2M | 1.4% | −74,200−12.0% | Reduced | Holders |
| Q1 2023 | 619,200 | $38.2M | 1.3% | −50,800−7.6% | Reduced | Holders |
| Q4 2022 | 670,000 | $51.7M | 1.2% | −868,600−56.5% | Reduced | Holders |
| Q3 2022 | 1,538,600 | $68.7M | 1.5% | +1,538,600 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −711,000−100.0% | Sold out | Holders |
| Q1 2022 | 711,000 | $29.4M | 0.7% | −64,000−8.3% | Reduced | Holders |
| Q4 2021 | 775,000 | $29.3M | 0.6% | +775,000 | New | Holders |